Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

BACKGROUND: Hypofractionated stereotactic body radiation therapy (SBRT) has been advanced as monotherapy for low-risk prostate cancer. We examined the dose distributions and early clinical outcomes using this modality for the treatment of intermediate-risk prostate cancer. METHODS: Forty-one sequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Andrew W, Wang, Hongkun, Oermann, Eric K, Sherer, Benjamin A, Uhm, Sunghae, Chen, Viola J, Pendharkar, Arjun V, Hanscom, Heather N, Kim, Joy S, Lei, Siyuan, Suy, Simeng, Lynch, John H, Dritschilo, Anatoly, Collins, Sean P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570380/
https://www.ncbi.nlm.nih.gov/pubmed/23369294
http://dx.doi.org/10.1186/1748-717X-8-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570380/
https://www.ncbi.nlm.nih.gov/pubmed/23369294
http://dx.doi.org/10.1186/1748-717X-8-30

Ejemplares similares